Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma

European Journal of Surgical Oncology

Volumn 26, Issue 7, 2000, Pages 657-662

  Werther, K ^a   Christensen, I J ^b   Brunner N ^b   Nielsen, H J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b FINSEN LABORATORY   (Denmark)

Author keywords

Angiogenesis; Colorectal cancer; Prognosis; Tumour progression; VEGF

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0033638716     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2000.0977     Document Type: Article

References (30)

1. Angiogenesis
2. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence
3. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging
4. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma
5. Vascular endothelial growth factor is a secreted angiogenic mitogen
6. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
7. Vascular endothelial growth factor
8. Vascular endothelial growth factor is up-regulated in the early premalignant stage of colorectal tumour progression
9. The classification of cancer of the colon and rectum
10. Outcome of surgery for colorectal cancer in a defined population in Sweden from 1984 to 1986
11. The effect of ranitidine on postoperative infectious complications after elective colorectal surgery
12. Clinical consequence of blood storage time
13. Angiogenesis
14. Vascular endothelial growth factor and its receptors
15. Biology and biochemistry of proteinases in tumor invasion
16. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells
17. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma
18. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
19. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
20. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
21. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblastic growth factor (bFGF) in patients with carcinoma and sarcoma
22. Preoperative serum endothelial growth factor can predict stage in colorectal cancer
23. A high pre-treatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
24. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
25. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease
26. In vitro release of vascular endothelial growth factor during platelet aggregation
27. Platelet count and survival in patients with colorectal cancer - A preliminary study
28. Thrombocytosis as a prognostic factor in women with cervical cancer
29. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation
30. Soluble vascular endothelial growth factor in various blood transfusion components